首页> 美国卫生研究院文献>other >Cytokine Combination Therapy Prediction for Bone Remodeling in Tissue Engineering Based on the Intracellular Signaling Pathway
【2h】

Cytokine Combination Therapy Prediction for Bone Remodeling in Tissue Engineering Based on the Intracellular Signaling Pathway

机译:基于细胞内信号通路的组织工程中骨质重塑的细胞因子联合治疗预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The long-term performance of tissue-engineered bone grafts is determined by a dynamic balance between bone regeneration and resorption. We proposed using embedded cytokine slow-releasing hydrogels to tune this balance toward a desirable final bone density. In this study we established a systems biology model, and quantitatively explored the combinatorial effects of delivered cytokines from hydrogels on final bone density. We hypothesized that: 1) bone regeneration was driven by transcription factors Runx2 and Osterix, which responded to released cytokines, such as Wnt, BMP2, and TGFβ, drove the development of osteoblast lineage, and contributed to bone mass generation; and 2) the osteoclast lineage, on the other hand, governed the bone resorption, and communications between these two lineages determined the dynamics of bone remodeling. In our model, Intracellular signaling pathways were represented by ordinary differential equations, while the intercellular communications and cellular population dynamics were modeled by stochastic differential equations. Effects of synergistic cytokine combinations were evaluated by Loewe index and Bliss index. Simulation results revealed that the Wnt/BMP2 combinations released from hydrogels showed best control of bone regeneration and synergistic effects, and suggested optimal dose ratios of given cytokine combinations released from hydrogels to most efficiently control the long-term bone remodeling. We revealed the characteristics of cytokine combinations of Wnt/BMP2 which could be used to guide the design of in vivo bone scaffolds and the clinical treatment of some diseases such as osteoporosis.
机译:组织工程化的骨移植物的长期性能取决于骨再生与吸收之间的动态平衡。我们建议使用嵌入的细胞因子缓释水凝胶将这种平衡调整到理想的最终骨密度。在这项研究中,我们建立了系统生物学模型,并定量研究了水凝胶中递送的细胞因子对最终骨密度的组合作用。我们假设:1)骨再生是由转录因子Runx2和Osterix驱动的,它们对释放的细胞因子(例如Wnt,BMP2和TGFβ)作出反应,驱动成骨细胞谱系的发展,并有助于骨量的产生。 2)另一方面,破骨细胞谱系支配着骨骼的吸收,这两个谱系之间的联系决定了骨骼重塑的动力。在我们的模型中,细胞内信号传导途径由常微分方程表示,而细胞间通讯和细胞种群动态则由随机微分方程建模。通过Loewe指数和Bliss指数评估协同细胞因子组合的作用。仿真结果表明,从水凝胶中释放的Wnt / BMP2组合显示出对骨再生和协同作用的最佳控制,并建议了从水凝胶中释放的给定细胞因子组合的最佳剂量比,以最有效地控制长期骨骼重塑。我们揭示了Wnt / BMP2的细胞因子组合的特征,可用于指导体内骨支架的设计以及某些疾病(例如骨质疏松症)的临床治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号